Medicxi Growth I LP 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-18 4:29 pm Purchase |
2020-08-11 | 13G | Checkmate Pharmaceuticals, Inc. CMPI |
Medicxi Growth I LP | 1,501,716 7.000% |
1,501,716 (New Position) |
Filing |